AMENDMENT NO. 5 TO CREDIT AND GUARANTY AGREEMENTCredit and Guaranty Agreement • January 19th, 2024 • Bioventus Inc. • Surgical & medical instruments & apparatus • New York
This CREDIT AND GUARANTY AGREEMENT, dated as of December 6, 2019 (as amended by that certain Amendment No. 1 to Credit and Guaranty Agreement dated as of August 29, 2021, Amendment No. 2 to Credit and Guaranty Agreement dated as of October 29, 2021, Amendment No. 3 to Credit and Guaranty Agreement dated as of July 11, 2022 and, Amendment No. 4 to Credit and Guaranty Agreement dated as of March 31, 2023, and Amendment No. 5 to Credit and Guaranty Agreement dated as of January 18, 2024), is by and among Bioventus LLC, a Delaware limited liability company (“Borrower”), certain Subsidiaries of the Borrower from time to time party hereto, as Guarantor Subsidiaries, the Lenders from time to time party hereto and Wells Fargo Bank, National Association, as administrative agent (together with its permitted successors in such capacity, the “Administrative Agent”) and as collateral agent (together with its permitted successors in such capacity, the “Collateral Agent”).
